ValiRx plc (AIM:VAL)

ValiRx Statistics

Total Valuation

ValiRx has a market cap or net worth of GBP 2.86 million. The enterprise value is 1.91 million.

Market Cap	2.86M
Enterprise Value	1.91M

Important Dates

The last earnings date was Friday, January 9, 2026.

Earnings Date	Jan 9, 2026
Ex-Dividend Date	n/a

Share Statistics

ValiRx has 742.80 million shares outstanding. The number of shares has increased by 116.98% in one year.

Current Share Class	742.80M
Shares Outstanding	742.80M
Shares Change (YoY)	+116.98%
Shares Change (QoQ)	+182.84%
Owned by Insiders (%)	9.62%
Owned by Institutions (%)	35.90%
Float	670.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	57.45
PB Ratio	0.95
P/TBV Ratio	2.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.07
EV / Sales	38.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.13

Financial Position

The company has a current ratio of 9.66, with a Debt / Equity ratio of 0.00.

Current Ratio	9.66
Quick Ratio	8.87
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-638.67

Financial Efficiency

Return on equity (ROE) is -57.69% and return on invested capital (ROIC) is -38.56%.

Return on Equity (ROE)	-57.69%
Return on Assets (ROA)	-37.13%
Return on Invested Capital (ROIC)	-38.56%
Return on Capital Employed (ROCE)	-66.99%
Revenue Per Employee	3,555
Profits Per Employee	-127,373
Employee Count	14
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-129,907
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.56% in the last 52 weeks. The beta is -0.75, so ValiRx's price volatility has been lower than the market average.

Beta (5Y)	-0.75
52-Week Price Change	-53.56%
50-Day Moving Average	0.33
200-Day Moving Average	0.49
Relative Strength Index (RSI)	53.43
Average Volume (20 Days)	13,854,220

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ValiRx had revenue of GBP 49,775 and -1.78 million in losses. Loss per share was -0.01.

Revenue	49,775
Gross Profit	49,775
Operating Income	-2.02M
Pretax Income	-2.01M
Net Income	-1.78M
EBITDA	-1.76M
EBIT	-2.02M
Loss Per Share	-0.01

Balance Sheet

The company has 518,794 in cash and 6,661 in debt, with a net cash position of 512,133 or 0.00 per share.

Cash & Cash Equivalents	518,794
Total Debt	6,661
Net Cash	512,133
Net Cash Per Share	0.00
Equity (Book Value)	3.01M
Book Value Per Share	0.01
Working Capital	757,134

Cash Flow

In the last 12 months, operating cash flow was -1.66 million and capital expenditures -21,237, giving a free cash flow of -1.69 million.

Operating Cash Flow	-1.66M
Capital Expenditures	-21,237
Free Cash Flow	-1.69M
FCF Per Share	-0.00

Margins

Gross Margin	100.00%
Operating Margin	-4,053.35%
Pretax Margin	-4,037.34%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ValiRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-116.98%
Shareholder Yield	-116.98%
Earnings Yield	-62.36%
FCF Yield	-58.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 6, 2020. It was a reverse split with a ratio of 0.008.

Last Split Date	Apr 6, 2020
Split Type	Reverse
Split Ratio	0.008

Scores

ValiRx has an Altman Z-Score of -3.41 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.41
Piotroski F-Score	3